Compare ENLT & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENLT | STAA |
|---|---|---|
| Founded | 2008 | 1982 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Ophthalmic Goods |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 1.2B |
| IPO Year | 2023 | N/A |
| Metric | ENLT | STAA |
|---|---|---|
| Price | $43.44 | $24.27 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 10 |
| Target Price | ★ $37.50 | $24.56 |
| AVG Volume (30 Days) | 30.0K | ★ 1.6M |
| Earning Date | 11-12-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 132.72 | N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | ★ $457,756,000.00 | $230,591,000.00 |
| Revenue This Year | $355.90 | N/A |
| Revenue Next Year | $42.83 | $22.61 |
| P/E Ratio | $43.59 | ★ N/A |
| Revenue Growth | ★ 27.72 | N/A |
| 52 Week Low | $14.01 | $13.50 |
| 52 Week High | $42.38 | $30.81 |
| Indicator | ENLT | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 67.95 | 45.52 |
| Support Level | $38.48 | $22.90 |
| Resistance Level | $40.03 | $26.18 |
| Average True Range (ATR) | 1.14 | 1.58 |
| MACD | 0.09 | -0.02 |
| Stochastic Oscillator | 91.24 | 29.59 |
Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, which produces its revenue from the sale of the electricity that is produced through wind energy and solar energy in Europe.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.